The Guidewire · Sole Intelligence
Vol. IIntelligence Brief № 14April 2026
Governance Brief · The Certification Question
A Resident's Intelligence Brief

The One Board Question

Two competing boards. Fifty years of parallel certification. A stalled unification effort, an antitrust fence, and a profession still divided at the credential line. Here is what's actually happening — and what it means for the residents who have to choose.

§ 01 — Orientation

What this is, why it matters

What This Is

A structured analysis of the movement to unify podiatric board certification under a single entity — the factions, the incentives, the legal guardrails, and the plausible pathways forward.

Why It Matters

Board certification drives hospital privileges, job offers, and how our profession is read by outsiders. Residents carry this decision into every credentialing committee for the next forty years.

§ 02 — The Landscape

Two boards, one specialty

Podiatry has two CPME-recognized certifying boards. Both emerged in the 1970s. Both have independent governance. Both have their own fee structures, exams, maintenance-of-certification requirements, and political constituencies. They compete for the same pool of residents graduating from the same accredited programs.

This is not how the rest of medicine works. MDs and DOs in almost every specialty certify through a single ABMS-recognized or AOA-recognized board. The podiatric profession's twin-board structure is a historical artifact — one that increasingly strains against modern credentialing systems, hospital privileging committees, and the expectations of the broader medical community.

ABPM

American Board of Podiatric Medicine · est. 1978

  • Certifies: Podiatric medicine & orthopedics
  • Recent move: Launched a Certificate of Added Qualification in Podiatric Surgery (2022)
  • Posture: Open to unification "for two decades"; frames itself as the willing negotiator
  • 2026 HOD action: CAQ in Podiatric Surgery discontinued

ABFAS

American Board of Foot and Ankle Surgery · est. 1975

  • Certifies: Foot surgery, and RRA surgery
  • Position: Case-review standards are non-negotiable; merger would "lower the bar"
  • Legal fence: Cites U.S. antitrust law as a reason not to engage in merger talks
  • Constituency: 10,000+ current diplomates; surgical residency programs
§ 03 — How We Got Here

A fifty-year timeline

1975

ABFAS established

Originally the National Board of Podiatric Surgery. First podiatric certifying board. Case-review model anchored from day one.

1978

ABPM established

Certifies in podiatric medicine and orthopedics. Independent governance, independent exam infrastructure.

2005

APMA Vision 2015 published

First formal profession-wide call for unified certification. ABPM later points to this document as proof of its long-standing willingness to unify.

2019

APMA Blue-Ribbon Panel

Reaffirms the policy of recognizing only one board per specialty area. Grants CPME autonomy over board recognition. Sets the table for everything that follows.

2022

ABPM CAQ in Podiatric Surgery launches

ABFAS responds immediately: the CAQ "accepts a lower level of competency" and skips surgical case review. The competition becomes overtly public.

2024

HOD Prop 2-24: One Board

APMA House of Delegates proposition calling for "One Board in Podiatric Medicine and Surgery" receives a Do Pass recommendation. Debate is contentious.

2024

Single Certifying Board Task Force

APMA convenes a task force. ABFAS sends a letter flagging antitrust exposure, declining to discuss competitively sensitive information, and criticizing the exclusion of other certifying entities.

2025

APMA and CPME statements

APMA (Dec) and CPME (Oct) independently state that CAQs are not equivalent to board or subspecialty certification. The ground begins to shift under ABPM's surgical CAQ.

2026

ABPM CAQ in Podiatric Surgery discontinued

At the March 2026 APMA HOD in Washington, DC, the surgical CAQ is formally discontinued. The most public flashpoint of the dispute is removed — but the underlying two-board structure remains.

"Engaging in discussions among this group of competing bodies and competing podiatrists presents significant risks of noncompliance with the antitrust laws."
— ABFAS letter to the APMA Single Certifying Board Task Force, 2024
§ 04 — Follow the Incentives

Who wants what, and why

Governance fights become readable once you stop asking what is the right answer and start asking who benefits from which outcome. Here is the incentive map.

ActorPreferred outcomeWhy
ABFAS Status quo preserved Dominant surgical credential. 10,000+ diplomates. Any merger dilutes the brand, pressures the case-review model, and redistributes institutional power.
ABPM Negotiated unification (or parity) Smaller institutional footprint. Unification either elevates ABPM's surgical legitimacy or creates a combined entity in which ABPM has formal standing.
APMA leadership Structural simplification Two competing boards generate member confusion, internal factions, and a harder sell to MD/DO-world credentialing systems. Unification is cleaner politics.
CPME Jurisdictional clarity Board recognition authority is CPME's. Autonomy granted in 2019 makes CPME the procedural gatekeeper of any formal unification pathway.
Residency programs Predictable credentialing A single recognized board simplifies alumni placement data, hospital credentialing conversations, and program competitiveness narratives.
Residents Not having to choose The current system forces a credentialing decision during residency that shapes the next 40 years of a career. Unification removes the choice — and the cost of picking wrong.
Hospital credentialing committees A single credential to reference They already struggle to distinguish ABPM from ABFAS. One board is administratively simpler and matches how they process MD/DO certifications.
AOFAS / AAOS Clearer podiatric credential to compare against The Joint Task Force with orthopedics is built around education and certification equivalency. A single, legible podiatric credential strengthens that conversation.
§ 05 — The Framework

Four pathways forward

Every governance problem has a limited set of possible resolutions. Here are the four credible ones, ranked by plausibility.

Pathway A — Most Likely

Parallel boards, new equilibrium

CAQ is gone. Both boards continue to certify within their recognized scopes. The profession lives with twin-board structure indefinitely, but with cleaner lanes and less overt conflict. Low friction, low resolution.

Pathway B — Watchable

CPME-driven consolidation

CPME, using its 2019-granted autonomy, formally recognizes only one unified podiatric specialty board. Requires a multi-year process, a new governance structure, and political cover to survive the antitrust and legal review. Possible, not fast.

Pathway C — Unlikely (near term)

Voluntary merger of ABFAS and ABPM

The boards themselves agree to unify. ABFAS has publicly rejected this pathway and explicitly cited antitrust risk in engaging. Would require a genuine shift in ABFAS's strategic posture. Not currently on the table.

Pathway D — Disruptor

External forcing function

Federal regulation, Medicare policy change, or an AMA/ABMS-driven equivalency framework compresses the timeline by making twin boards operationally untenable. Low probability, high impact if triggered.

§ 06 — Key Concepts

Terms to know cold

CPME

Council on Podiatric Medical Education. The accrediting and recognizing body. Accredits residency programs and recognizes certifying boards. Holds the procedural keys to any formal unification pathway.

JCRSB

Joint Committee on the Recognition of Specialty Boards. The arm of CPME and APMA that formally recognizes podiatric certifying boards. The obscure acronym where the actual mechanics live.

CAQ

Certificate of Added Qualification. A credential issued independent of primary board certification. APMA and CPME both stated in 2025 that CAQs are not equivalent to board or subspecialty certification. The 2026 HOD discontinued ABPM's surgical CAQ.

Antitrust exposure

The legal reason ABFAS gives for not engaging in merger discussions. Two competing certifying entities coordinating on credentialing standards can, in theory, trigger federal antitrust scrutiny — particularly around anti-competitive collusion or group boycotts.

Vision 2015 / Blue-Ribbon Panel

The two foundational APMA policy documents — from 2005 and 2019 respectively — that establish the profession's formal preference for one board per specialty area. The political anchor for every subsequent unification argument.

Joint Task Force of Orthopaedic & Podiatric Surgeons

AAOS, AOFAS, ACFAS, and APMA. Active since 2018. Works on education and certification equivalency. The external context that makes podiatry's internal two-board structure look increasingly out of step.

§ 07 — For Residents & Students

Pitfalls & pearls

⚠ Pitfalls
  1. Treating this as settled. The CAQ is gone. The two-board structure is not.
  2. Picking a board based on slogans. Choose based on scope of practice, case requirements, pass rates, and hospital credentialing patterns in the region where you plan to practice.
  3. Assuming unification means easier. A merged board would almost certainly inherit ABFAS's case-review model. Unification is not a shortcut.
  4. Ignoring the antitrust framing. It's not just legal theater — it is the actual reason voluntary merger talks are structurally difficult.
  5. Confusing CAQs with board certification. APMA, CPME, and ABFAS have all stated on the record that they are not equivalent.
◆ Pearls
  1. Watch CPME, not APMA. APMA sets policy. CPME recognizes boards. The procedural gatekeeper is where the real decision lives.
  2. Follow the delegates. HOD resolution language is where direction is set. Read the resolves, not the whereas clauses.
  3. The Joint Task Force matters. External equivalency pressure with orthopedics is the most credible long-horizon forcing function.
  4. Hospital credentialing is the real battleground. Not podiatric politics. Credentialing committees are where board certification decisions get cashed in.
  5. Pay attention to language shifts. The move from "competing boards" to "recognized certifying entities" to "unified board" is linguistic ground being prepared for structural change.
Analyst Confidence

7/10 — Medium-high. Historical events and published organizational positions are well-documented. The pathway ranking in § 05 reflects a reading of current institutional incentives, not a prediction. The 2026 HOD outcome is recent; secondary ripple effects will clarify over the next 12–18 months. ⚠ Verify local credentialing patterns before applying this to any personal decision.

Primary Sources

  1. ABFAS. Letter re: APMA Single Certifying Board Task Force. 2024.
  2. ABPM. "Moving Forward" statement on CAQ in Podiatric Surgery. 2023.
  3. ABFAS. Response to the ABPM CAQ (and related statements, 2022 — present).
  4. APMA. Certification and Membership Organizations in Podiatry guide; Blue-Ribbon Panel summary, 2019.
  5. APMA. Statement on Certificates of Added Qualification. December 2025.
  6. CPME. Statement on CAQs. October 2025.
  7. APMA. Joint Task Force of Orthopaedic and Podiatric Surgeons — Announcement. May 2021.
  8. HOD records: Proposition 2-24 (2024); CAQ discontinuation action (March 2026).
AI-ASSISTED CONTENT. Produced with LLM assistance. Reviewed and approved by Peter Sorensen, DPM. Educational and analytical only — not legal, financial, or clinical advice. This brief summarizes publicly available organizational positions and historical documents. Characterization of motives, incentives, and pathways reflects the author's analytical reading and should not be taken as official statement of any organization referenced. Verify primary sources before citing.